CATALIS Welcomes Two New Board Members

CATALIS’s Board of Directors brings together experts from Quebec healthcare institutions, pharmaceutical companies, and independent directors. Guided by the principles of sound governance, the Board helps shape the organization’s strategic direction and supports the deployment of initiatives aimed at accelerating the development of innovative treatments for the benefit of patients across Quebec.

CATALIS is pleased to announce the appointment of Dominique Johnson, PhD, and Pascal Martel, FCPA, to its Board of Directors.

Their addition strengthens the Board’s collective expertise and supports CATALIS in fulfilling its mission to optimize Quebec’s clinical research environment through collaboration among the various stakeholders in the ecosystem.

Welcome to Dominique Johnson

Since 2016, when she was appointed Executive Director of the McPeak-Sirois Group for Clinical Research in Breast Cancer, Dr. Dominique Johnson has drawn on more than 30 years of clinical research experience to engage hospital centres and their teams and advance the Group’s activities.

A graduate of the Université de Montréal with a PhD in Biomedical Sciences, specializing in cardiovascular clinical research, Dr. Johnson has worked across the public and private sectors as well as in the pharmaceutical industry. In 2000, she co-founded the clinical trials coordination center at the Montreal Heart Institute (MHICC, now Seriant), where she served as Executive Director for 16 years and led its development and growth to international recognition.

In 2021, under her leadership, Quebec’s first registry dedicated to metastatic breast cancer was launched. She has also served on governance and operations committees for several major international clinical trials and has developed numerous partnerships across the clinical research community. Dr. Johnson is the author of more than 40 scientific publications.

Welcome to Pascal Martel

As Managing Partner, Tax and Legal Services for the Province of Quebec at KPMG, Pascal Martel is widely recognized as an influential leader in the field of taxation in Quebec. An experienced strategist, he has built and now leads one of the largest tax practices among Canada’s major consulting firms, a testament to his ability to combine technical excellence, strategic vision, and a strong commitment to the common good. As an architect of KPMG Quebec’s sustained growth, he has fostered a culture rooted in rigour, transparency, and innovation while promoting diversity, equity, and talent development.

A recognized expert in tax incentives, particularly in scientific research and experimental development, he has played a significant role in shaping both provincial and federal tax policies. Frequently called upon by the Canada Revenue Agency, Revenu Québec, and the Association de planification fiscale et financière (Association for Fiscal and Financial Planning), he has contributed for more than 15 years to the advancement of best practices, the training of future professionals, and the promotion of French-language expertise in taxation.

Deeply committed to his community, he dedicates his time and expertise to several non-profit organizations.

The Board Thanks Diane Gosselin and Monique Lacroix as Their Terms Come to an End

CATALIS would also like to recognize the contributions of Diane Gosselin and Monique Lacroix, who have served on the Board of Directors for many years.

Throughout their tenure, they helped guide the organization’s evolution through their expertise, commitment, and active participation in Board discussions. Their contributions supported CATALIS’s growth and strengthened its ability to meet the needs of Quebec’s clinical research ecosystem.

With the addition of Dominique Johnson and Pascal Martel, CATALIS continues its commitment to bringing together diverse expertise to support the advancement of clinical research in Québec and contribute to an increasingly innovative and collaborative environment. On behalf of the entire CATALIS Quebec team, thank you!